RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 29, 2026, 19:40The Great Egg Escape: Understanding Premature Ovulation in IVF – Fertility Plus
-
May 29, 2026, 19:38Devyanshi Dixit: Call for Abstract for GFWH 2026
-
May 29, 2026, 19:35Tom Holland: Advancing Robotic Surgery Skills at the T400 Course in Strasbourg
-
May 29, 2026, 19:33Silpi Saikia: Not Every Successful Blastocyst Comes From an Easy Case!
-
May 29, 2026, 19:31Register Now and Secure Your Spot at ASRM 2026 – ASRM
-
May 29, 2026, 19:29Sonam Jain: The Real Driver of IVF Conversion Is Patient Trust
-
May 29, 2026, 19:26Mediterranean Diet Before IVF Increases Successful Pregnancies by 40%! – Fertility Plus
-
May 29, 2026, 19:24Melanie Norton: Excited to Begin My Robotics Fellowship at UCLH
-
May 29, 2026, 19:22A Step Forward in Non-Invasive Diagnosis of Endometriosis – The Lancet Medical Imaging and Theranostics